02.09.2014 23:25:11
|
Epizyme CFO Jason Rhodes Resigns
(RTTNews) - Epizyme Inc (EPZM), a clinical stage biopharmaceutical company focusing on genetically defined cancers, said Tuesday its Chief Financial Officer Jason Rhodes would resign from the company, effective September 30. Rhodes will be joining a venture capital firm.
The company has a search underway to identify a new CFO, and Rhodes has agreed to assist Epizyme in an advisory capacity through the end of 2014 to ensure a smooth transition.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Epizyme Incmehr Nachrichten
Keine Nachrichten verfügbar. |